Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
3-Chlorobenzenesulfonamide → N-[({2-[4-(3,5-Dimethyl-4-phenyl-1H-pyrazol-1-yl)phenyl]ethyl}amino)carbonyl]-3-chlorobenzenesulfonamide
참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|---|---|---|
| 반응물 | 3-Chlorobenzenesulfonamide | HCID 519377 | — |
| 반응물 | Phenyl 2-[4-(3,5-dimethyl-4-phenyl-1H-pyrazol-1-yl)phenyl]ethylcarbamate | HCID 22244550 | — |
| 생성물 | N-[({2-[4-(3,5-Dimethyl-4-phenyl-1H-pyrazol-1-yl)phenyl]ethyl}amino)carbonyl]-3-chlorobenzenesulfonamide | HCID 22244602 | — |
반응 단계
The title compound was prepared according to the procedure described in step 2 of Example 22 from phenyl 2-[4-(3,5-dimethyl-4-phenyl-1H-pyrazol-1-yl)phenyl]ethylcarbamate (step 1 of Example 22) and 3-chlorobenzenesulfonamide: 1H-NMR (CDCl3) δ 7.91-7.90 (1H, m), 7.83-7.79 (1H, m), 7.53-7.20 (11H, m), 6.32 (1H, br.s), 3.47-3.40 (2H, m), 2.81 (2H, t, J=6.6 Hz), 2.30 (3H, s), 2.22 (3H, s).
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| 특허 번호 | US07001917B2 |
| 출처 데이터셋 | uspto-grants-2006_02 |
| ORD ID | ord-320dec2d673e44ff8215718c4d713950 |
| 출처 메모 | uspto-grants-2006_02 |